Navigation Links
Fox Chase Cancer Center signs agreement with Life Technologies Corp.
Date:6/13/2011

the initiative is to combine several institutional resources and a multidisciplinary team including scientists and clinicians to evaluate the ways that genomic sequencing can be used in patient management. Fox Chase clinicians will be able to assess a genomic analysis of a patient's tumor compared to their normal tissues. The service will utilize Life Technologies' sequencing and analysis platforms, including the SOLiD system, Ion Torrent semiconductor sequencing, and novel biological information technology systems for analysis of genomic data. It is expected that with appropriate resources and after rigorous testing and validation studies, genome sequencing can become a broadly used diagnostic tool integrated into the standard management of patients with cancer.

"We are proud to power the innovations in cancer care that Fox Chase Cancer Center researchers and clinicians will make," said Greg Lucier, chairman and CEO of Life Technologies. "We expect this model of industry and academic collaboration to demonstrate the effectiveness of sequencing in improving patient care."

The technology will also enable the Cancer Genome Institute at Fox Chase to create a genomic knowledge database. With patient consent, information linking the patient's tumor genotype, the oncologist's recommendation of targeted therapy, and the patient's clinical outcome will be made available to the research and clinical oncology community at large, while protecting the identity of the patient. The database will build on Fox Chase's already substantial Biosample Repository to add a critical additional layer of new knowledge about the genetic information in individual patient tumors.

Fox Chase will also use the database to accelerate the development of new cancer treatments through collaboration with its highly regarded phase 1 clinical trials program, which tests a broad spectrum of novel cancer therapeutics in patients with advanced cancer. The genetic informatio
'/>"/>

Contact: Kristin Hummel
khummel@tierneyagency.com
215-790-4343
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study: Lowering cost doesnt increase hearing aid purchases
2. Fox Chase researchers find that fish oil boosts responses to breast cancer drug tamoxifen
3. Fox Chase researchers report that naproxen reduces tumors in a mouse model of colon cancer
4. Fox Chase scientists report interplay between cancer and aging in mice
5. Fox Chase researchers develop a screen for identifying new anticancer drug targets
6. Calorie labeling has no effect on teenagers or parents food purchases
7. Fox Chase researchers uncover new risk factors for brain metastases in breast cancer patients
8. Fox Chase researchers identify risk factors for the spread of breast cancer to lymph nodes
9. Cash is healthier? Credit and debit increase impulsive food purchases
10. CerMedia Completes Purchase of Cell-Pore Principal Assets from NanoDynamics
11. Fox Chase clinical trial tests first of its kind antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... , ... The 28th annual Charity Horse Show hosted by the Mid-South Horse ... p.m. in Pugh Bourne Park, 343 Oakfield Road. The event will again benefit Youth ... impersonator, a silent auction and concessions. , Horses and riders from around the country ...
(Date:7/1/2015)... Florida (PRWEB) , ... July 01, 2015 , ... Trevor ... University of South Florida and continued at USF earning a Master’s degree in Microbiology. ... an active member of the American Dental Association, the Florida Dental Association and the ...
(Date:7/1/2015)... ... July 01, 2015 , ... Boar’s Head Brand®, one ... ready for Independence Day celebrations with new takes on classic dishes. From chicken ... perfect for any summertime get together. , “Celebrating with family, friends, and great ...
(Date:7/1/2015)... ... July 01, 2015 , ... B. E. Smith, the only full-service leadership ... chief nursing officer recruitment for Capital Health in Pennington, N.J. ... E. Smith has recently placed more than 1,000 healthcare executives into organizations. , ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Incentivizing the use ... under control, with discounts as much as 80% or 90% off the prices for ... insurers need to act to mitigate the financial impact of these high-cost generic drugs. ...
Breaking Medicine News(10 mins):Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3
... ALAMITOS, Calif., July 7 Traditional medicine,attempts to treat ... underlying causes. As a result, menopausal women may have ... Solutions, a,woman may significantly decrease her menopausal symptoms using ... healing is to remove or reduce all of the ...
... housekeeping enzyme has been found to play a major ... can nurture hematopoietic,stem cells, MEMPHIS, Tenn., July 7 ... as a run-of-the-mill enzyme that helps to,recycle molecules in ... according to St. Jude Children,s Research Hospital investigators., ...
... Children as young as 2 should be tested for high ... In a further concession to the impact of the childhood ... pediatricians is recommending that kids as young as 8 years ... problems later in life. , The American Academy of Pediatrics ...
... July 7 Joel Madden, lead vocalist,for the ... UNICEF,s newest Goodwill Ambassador, officials with the U.S.,Fund ... Sunday during a cable broadcast on global child ... Time, which aired on CNN and,was hosted by ...
... NEW YORK, July 7 Many people ... complication associated with diabetes -- serious gum,disease. ... health and diabetes., Listen to ... Registered journalists can access video, audio, ...
... July 7 iCAD, Inc. (Nasdaq:,ICAD), an industry-leading ... identification of cancer, today announced that the,Company,s second ... open on Thursday, July 31, 2008. iCAD management ... for 10:00 a.m. ET that same,morning., Shareholders ...
Cached Medicine News:Health News:Holistic Health Solutions Offers a Long Awaited Relief for Menopausal Symptoms 2Health News:St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease 2Health News:St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease 3Health News:St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease 4Health News:Pediatricians Recommend Cholesterol Drugs for Some Kids 2Health News:Pediatricians Recommend Cholesterol Drugs for Some Kids 3Health News:Rocker Joel Madden Named Newest UNICEF Goodwill Ambassador 2Health News:iCAD to Host Second Quarter 2008 Financial Results Conference Call on Thursday, July 31, 2008 2Health News:iCAD to Host Second Quarter 2008 Financial Results Conference Call on Thursday, July 31, 2008 3
(Date:7/1/2015)... , July 1, 2015  BioPharmX Corporation (NYSE ... announced underwritten public offering of 3,636,364 shares of its ... $2.75 per share. BioPharmX has granted the underwriters a ... of common stock at the public offering price. ... Fund, an existing stockholder, has agreed to purchase 1,081,081 ...
(Date:7/1/2015)... 2015 The global mHealth ... USD 49,119.2 million by 2020, according to a new ... expected to remain the dominant and fastest growing market ... 2012, and an estimated CAGR of 49.7% from 2014 ... , Browse full research report with TOC ...
(Date:7/1/2015)... , July 1, 2015 ... its Executive Board. Mr. Gert Weber has ... Invest AG as Chief Executive Officer (CEO) ... July 1 st , 2015. Mr. Weber brings more ... technological industries and has filled various executive management positions, ...
Breaking Medicine Technology:BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2
... 2011 Seal Shield LLC today announced ... for the iPad.  The product has been designed specifically ... use in hospital settings. The Seal Shield ... which is resistant to liquids including blood and bleach. ...
... MALVERN, Pa., Feb. 21, 2011 Today, Siemens (NYSE: ... Overhage, MD, PhD, as Chief Medical Informatics Officer (CMIO), of ... of the In diana Health Information Exchange ... this not-for-profit organization. In his role at Siemens, Marc will ...
Cached Medicine Technology:Siemens Appoints Overhage as New Chief Medical Informatics Officer 2
Naugle exophthalmometer is superior and inferior orbital rim-based instrument....
... easy-to-fit, daily disposable, spherical ... cast-mold technology, and designed ... correction of myopia and ... disposable contact lenses are ...
Both corneal topography and refractive error data are measured together in a single step to minimize alignment errors. Objective autorefractometry and autokeratometric readings of sphere, cylinder an...
... The only corneal topographer available ... optional built-in Pupillometer.,The German-engineered Keratograph delivers ... equally well for refractive surgery or ... exclusive optional infrared Pupillometer allows the ...
Medicine Products: